98 related articles for article (PubMed ID: 12943504)
1. Effects of human presenilin 1 isoforms on proliferation and survival of rat pheochromocytoma cell line PC12.
Bobrysheva IV; Grigorenko AP; Novosadova EV; Kal'ina NR; Arsenyeva EL; Grivennikov IA; Tarantul VZ; Rogaev EI
Biochemistry (Mosc); 2003 Jun; 68(6):611-7. PubMed ID: 12943504
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis.
Tanii H; Ankarcrona M; Flood F; Nilsberth C; Mehta ND; Perez-Tur J; Winblad B; Benedikz E; Cowburn RF
Neuroscience; 2000; 95(2):593-601. PubMed ID: 10658639
[TBL] [Abstract][Full Text] [Related]
3. Twenty-nine missense mutations linked with familial Alzheimer's disease alter the processing of presenilin 1.
Murayama O; Murayama M; Honda T; Sun X; Nihonmatsu N; Takashima A
Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jul; 23(5):905-13. PubMed ID: 10509383
[TBL] [Abstract][Full Text] [Related]
4. Different effects of Alzheimer-associated mutations of presenilin 1 on its processing.
Murayama O; Honda T; Mercken M; Murayama M; Yasutake K; Nihonmatsu N; Nakazato Y; Michel G; Song S; Sato K; Takahashi H; Takashima A
Neurosci Lett; 1997 Jun; 229(1):61-4. PubMed ID: 9224802
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals.
Guo Q; Sopher BL; Furukawa K; Pham DG; Robinson N; Martin GM; Mattson MP
J Neurosci; 1997 Jun; 17(11):4212-22. PubMed ID: 9151738
[TBL] [Abstract][Full Text] [Related]
6. Processing of wild-type and mutant familial Alzheimer's disease-associated presenilin-1 in cultured neurons.
Weihl CC; Ghadge GD; Miller RJ; Roos RP
J Neurochem; 1999 Jul; 73(1):31-40. PubMed ID: 10386952
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: Evidence that Alzheimer mutations affect proteolytic processing.
Mercken M; Takahashi H; Honda T; Sato K; Murayama M; Nakazato Y; Noguchi K; Imahori K; Takashima A
FEBS Lett; 1996 Jul; 389(3):297-303. PubMed ID: 8766720
[TBL] [Abstract][Full Text] [Related]
8. The presenilin 1 mutation (M146V) linked to familial Alzheimer's disease attenuates the neuronal differentiation of NTera 2 cells.
Tokuhiro S; Tomita T; Iwata H; Kosaka T; Saido TC; Maruyama K; Iwatsubo T
Biochem Biophys Res Commun; 1998 Mar; 244(3):751-5. PubMed ID: 9535737
[TBL] [Abstract][Full Text] [Related]
9. Increased Abeta42(43) from cell lines expressing presenilin 1 mutations.
Mehta ND; Refolo LM; Eckman C; Sanders S; Yager D; Perez-Tur J; Younkin S; Duff K; Hardy J; Hutton M
Ann Neurol; 1998 Feb; 43(2):256-8. PubMed ID: 9485068
[TBL] [Abstract][Full Text] [Related]
10. Aberrant induction of Par-4 is involved in apoptosis of hippocampal neurons in presenilin-1 M146V mutant knock-in mice.
Xie J; Chang X; Zhang X; Guo Q
Brain Res; 2001 Oct; 915(1):1-10. PubMed ID: 11578614
[TBL] [Abstract][Full Text] [Related]
11. Presenilin-1 protein expression in familial and sporadic Alzheimer's disease.
Levey AI; Heilman CJ; Lah JJ; Nash NR; Rees HD; Wakai M; Mirra SS; Rye DB; Nochlin D; Bird TD; Mufson EJ
Ann Neurol; 1997 Jun; 41(6):742-53. PubMed ID: 9189035
[TBL] [Abstract][Full Text] [Related]
12. Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein.
Citron M; Eckman CB; Diehl TS; Corcoran C; Ostaszewski BL; Xia W; Levesque G; St George Hyslop P; Younkin SG; Selkoe DJ
Neurobiol Dis; 1998 Aug; 5(2):107-16. PubMed ID: 9746908
[TBL] [Abstract][Full Text] [Related]
13. Developmental expression of wild-type and mutant presenilin-1 in hippocampal neurons from transgenic mice: evidence for novel species-specific properties of human presenilin-1.
Lévesque L; Annaert W; Craessaerts K; Mathews PM; Seeger M; Nixon RA; Van Leuven F; Gandy S; Westaway D; St George-Hyslop P; De Strooper B; Fraser PE
Mol Med; 1999 Aug; 5(8):542-54. PubMed ID: 10501657
[TBL] [Abstract][Full Text] [Related]
14. Human wild presenilin-1 mimics the effect of the mutant presenilin-1 on the processing of Alzheimer's amyloid precursor protein in PC12D cells.
Kametani F; Tanaka K; Usami M; Maruyama K; Mori H
J Neurol Sci; 2001 Jul; 188(1-2):27-31. PubMed ID: 11489281
[TBL] [Abstract][Full Text] [Related]
15. The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice.
Wen PH; Hof PR; Chen X; Gluck K; Austin G; Younkin SG; Younkin LH; DeGasperi R; Gama Sosa MA; Robakis NK; Haroutunian V; Elder GA
Exp Neurol; 2004 Aug; 188(2):224-37. PubMed ID: 15246822
[TBL] [Abstract][Full Text] [Related]
16. Numb isoforms containing a short PTB domain promote neurotrophic factor-induced differentiation and neurotrophic factor withdrawal-induced death of PC12 Cells.
Pedersen WA; Chan SL; Zhu H; Abdur-Rahman LA; Verdi JM; Mattson MP
J Neurochem; 2002 Aug; 82(4):976-86. PubMed ID: 12358803
[TBL] [Abstract][Full Text] [Related]
17. Nerve growth factor-independent reduction in choline acetyltransferase activity in PC12 cells expressing mutant presenilin-1.
Pedersen WA; Guo Q; Hartman BK; Mattson MP
J Biol Chem; 1997 Sep; 272(36):22397-400. PubMed ID: 9278388
[TBL] [Abstract][Full Text] [Related]
18. Staurosporine-induced activation of caspase-3 is potentiated by presenilin 1 familial Alzheimer's disease mutations in human neuroglioma cells.
Kovacs DM; Mancini R; Henderson J; Na SJ; Schmidt SD; Kim TW; Tanzi RE
J Neurochem; 1999 Dec; 73(6):2278-85. PubMed ID: 10582585
[TBL] [Abstract][Full Text] [Related]
19. Abnormal intracellular trafficking of high affinity nerve growth factor receptor, Trk, in stable transfectants expressing presenilin 1 protein.
Hamano T; Mutoh T; Tabira T; Araki W; Kuriyama M; Mihara T; Yano S; Yamamoto H
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):70-6. PubMed ID: 15950763
[TBL] [Abstract][Full Text] [Related]
20. Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.
Lee J; Chan SL; Mattson MP
Neuromolecular Med; 2002; 2(1):29-45. PubMed ID: 12230303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
